Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)A First-in-Human SAD/MAD Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ENC1018 in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: ENC1018 for SADDrug: Placebo for SADDrug: ENC1018 for MADDrug: Placebo for MAD
- First Posted Date
- 2024-01-25
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- EnnovaBio Australia Pharmaceuticals Pty Ltd
- Target Recruit Count
- 72
- Registration Number
- NCT06224400
- Locations
- 🇦🇺
Nucleus Network Pty Ltd., Melbourne, Victoria, Australia
A First-in-human Single Ascending Dose/Multiple Ascending Dose Study of ENN0403 in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: ENN0403 4mgDrug: ENN0403 10mgDrug: ENN0403 1mgDrug: ENN0403 12mg QD X 14 DaysDrug: ENN0403 20mg QD X 14 DaysDrug: ENN0403 20mgDrug: ENN0403 30mgDrug: ENN0403 20mg (Fed)Drug: ENN0403 6mg QD X 14 DaysDrug: Placebo
- First Posted Date
- 2022-08-18
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- EnnovaBio Australia Pharmaceuticals Pty Ltd
- Target Recruit Count
- 69
- Registration Number
- NCT05506540
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, Australia
News
No news found